BGM · BGM Group Ltd
United States · RS rating 53 · As of 2026-10-14
| Price | 9.55 USD |
|---|---|
| 1-day change | -8.9% |
| RS rating (overall / 1M / 3M / 12M) | 53 / 97 / 84 / 2 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 19 / 8 |
| Industry group (rank) | Medical-Generic Drugs (94) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +96.8% |
| Market cap (USD) | $65.8M |